SAN FRANCISCO (AP) - Federal prosecutors in San Francisco say Genentech and OSI Pharmaceuticals have agreed to pay $67 million to settle allegations they misled doctors about the effectiveness of a cancer drug.
The U.S. attorney's office in Northern California announced the settlement on Monday.
Genentech, OSI to pay $67M over cancer drug allegations
Aucun commentaire:
Enregistrer un commentaire